Expression of the cancer stem cell marker OCT4 is associated with worse prognosis and survival in cutaneous melanoma.

Silva CThaise Xav, Saddi VAparecida, Silva KSantiago F, Sugita DMasashi, Guillo LAndreu. Expression of the cancer stem cell marker OCT4 is associated with worse prognosis and survival in cutaneous melanoma. Melanoma Res. 2021.